Comparison of Two Endovascular Interventions with Low-Profile Visualized Intraluminal Support or Pipeline Embolization Device in Middle Cerebral Arterial Aneurysms Patients

医学 改良兰金量表 栓塞 外科 格拉斯哥结局量表 动脉瘤 纸牌密码算法 栓塞 脑栓塞 支架 大脑中动脉 放射科 格拉斯哥昏迷指数 缺血 内科学 缺血性中风
作者
Zhonghua Lv,Yilin Zhu,Wei Wang,Qiangjun Wu,Wen Li,Qiang Li,Liang Xu
出处
期刊:Journal of Investigative Surgery [Informa]
卷期号:34 (6): 590-594 被引量:2
标识
DOI:10.1080/08941939.2019.1670883
摘要

This study aims to compare efficacy and safety of Low-profile Visualized Intraluminal Support (LVIS) stent and Pipeline Embolization Device (PED)-assisted endovascular interventions in patients with middle cerebral arterial aneurysms.This retrospective study included a total of 144 MCA patients, who went to our hospital from January 2013 to December 2017. These patients were divided into two groups: LVIS group, 81 cases; PED group, 63 cases. Then, the basic clinical characteristics were collected. The Raymond grade was used to evaluate the embolism immediately after the surgery and at six months after surgery. The Glasgow Outcome Scale (GOS) and modified Rankin scale were used at six months after surgery, and the recurrence rate was also recorded.The mean aneurysm diameter was 7.7 ± 5.1, which range from 2-25 mm. There were 25 cases with ruptured aneurysms. The results revealed that 57 (70.4%) cases in the LVIS group and 41 (65.1%) cases in the PED group presented with complete embolisms immediately after the surgery. The mean GOS score after six months was 4.6 ± 0.9 in the LVIS group and 4.6 ± 0.9 in the PED group. Furthermore, a total of 86.4% cases had a good prognosis in the LVIS group, while 87.3% cases had a good prognosis in the PED group. Moreover, recurrence was found in six (7.4%) cases in the LVIS group and in five (7.9%) cases in the PED group.Both these two methods are effective and safe, with a high good prognosis rate and low recurrence. However, there was no significant difference between the PED and LVIS stent methods.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
坦率的从波完成签到 ,获得积分10
刚刚
SciGPT应助EaRnn采纳,获得10
1秒前
zijinbeier完成签到,获得积分10
3秒前
14秒前
小亮哈哈完成签到,获得积分0
15秒前
水晶李完成签到 ,获得积分10
19秒前
卓矢完成签到 ,获得积分10
21秒前
25秒前
651完成签到 ,获得积分10
27秒前
momo完成签到,获得积分10
32秒前
嘚嘚发布了新的文献求助10
32秒前
兜兜揣满糖完成签到 ,获得积分10
44秒前
bc完成签到,获得积分10
53秒前
55秒前
文与武完成签到 ,获得积分10
1分钟前
啦啦啦完成签到 ,获得积分10
1分钟前
linmu完成签到 ,获得积分10
1分钟前
aowulan完成签到 ,获得积分10
1分钟前
今后应助yuyuyu采纳,获得10
1分钟前
万灵竹完成签到 ,获得积分10
1分钟前
娟儿完成签到 ,获得积分10
1分钟前
wjswift完成签到,获得积分10
1分钟前
淡淡菠萝完成签到 ,获得积分10
1分钟前
1分钟前
小静完成签到 ,获得积分10
1分钟前
1分钟前
EaRnn发布了新的文献求助10
1分钟前
顾矜应助pgyq采纳,获得10
1分钟前
蓝桉完成签到 ,获得积分10
1分钟前
Cao完成签到 ,获得积分10
1分钟前
苻醉山完成签到 ,获得积分10
2分钟前
牛奶面包完成签到 ,获得积分10
2分钟前
Hiram完成签到,获得积分10
2分钟前
Allot完成签到,获得积分10
2分钟前
鞑靼完成签到 ,获得积分10
2分钟前
yxq完成签到 ,获得积分10
2分钟前
CoCo完成签到 ,获得积分10
2分钟前
mimilv完成签到,获得积分10
2分钟前
fogsea完成签到,获得积分0
2分钟前
kanong完成签到,获得积分0
2分钟前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Aspects of Babylonian celestial divination : the lunar eclipse tablets of enuma anu enlil 1500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
体心立方金属铌、钽及其硼化物中滑移与孪生机制的研究 800
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3450467
求助须知:如何正确求助?哪些是违规求助? 3045952
关于积分的说明 9003806
捐赠科研通 2734611
什么是DOI,文献DOI怎么找? 1500096
科研通“疑难数据库(出版商)”最低求助积分说明 693341
邀请新用户注册赠送积分活动 691477